10-K: Precision Optics Corp. Reports Revenue Growth Amidst Financial Challenges

Precision Optics Corporation, Inc. filed its annual report, highlighting a significant revenue increase driven by systems manufacturing, but also detailing ongoing net losses and a recent debt covenant waiver.

Summary

• Precision Optics Corporation, Inc. reported total revenues of $31,531,765 for the fiscal year ended June 30, 2026, a 65.2% increase from $19,091,269 in the prior year.
• The company experienced a net loss of $3,629,891 for the fiscal year ended June 30, 2026, compared to a net loss of $5,780,246 for the prior year.
• Revenue from Systems Manufacturing saw a substantial increase of 172.9%, while Engineering Design Services decreased by 29.7% and MicroOptics Lab decreased by 75.7%.
• The company secured a waiver from Main Street Bank for its minimum annual debt service coverage covenant for the fiscal year ended June 30, 2026, and replaced it with a minimum liquidity covenant of $2,000,000.
• As of June 30, 2026, the company had $9,841,142 in cash and cash equivalents, an increase from $1,773,735 in the prior year.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this filing as cautiously negative due to the continued net losses, increased customer concentration, and the recent covenant waiver, despite revenue growth.

Positives

• Total revenues increased by 65.2% to $31,531,765 for the fiscal year ended June 30, 2026.
• Systems Manufacturing revenue grew significantly by 172.9%.
• Ross Optical Industries revenue increased by 31.7%.
• Net loss decreased to $3,629,891 from $5,780,246 in the prior year.
• Cash and cash equivalents increased substantially to $9,841,142 from $1,773,735.
• The company successfully completed an equity raise of $10,630,678 in March 2026.

Negatives

• The company incurred a net loss of $3,629,891 for the fiscal year ended June 30, 2026.
• Customer concentration increased significantly, with two customers accounting for 41% and 27% of total revenues in FY2026, compared to 22% and 20% in FY2025.
• Engineering Design Services revenue decreased by 29.7%.
• MicroOptics Lab revenue decreased by 75.7% due to delays in production orders.
• The company did not meet its minimum annual debt service coverage covenant for FY2026, requiring a waiver from the bank.
• Gross margin slightly decreased to 17.2% from 17.8%.

Risks

• The company has a history of losses and may continue to incur losses, potentially requiring additional funds.
• Reliance on a small number of customers poses a significant risk; the loss of any of these customers could materially affect revenues.
• The company may suffer unrecoverable losses on customer accounts receivable.
• The loss of key personnel, particularly the CEO, could damage the business.
• Failure to attract and retain employees with necessary scientific and technical skills could severely damage the business.
• The company is subject to significant regulatory oversight (FDA, ITAR), and failure to maintain approvals could lead to revenue decline.
• Risks associated with product development and production under fixed-price purchase orders, which may not be profitable over time.
• Dependence on a limited number of suppliers for key materials like precision-grade optical glass and CMOS sensors.

Future Outlook

Management believes that available cash, cash generated from operations, line of credit availability, and the ability to raise capital will be sufficient to meet working capital and capital expenditure requirements for at least 12 months from the filing date. The company expects revenue to increase over time as new product programs transition to commercial phases.

Management Comments

• "We generally expect revenue to increase over time as the engineering design phase of new product programs is completed and products transition to the commercial phase, leveraging our unique manufacturing capabilities."
• "Much of the technology we have developed for making smaller medical devices is also used in defense and aerospace systems where smaller size and weight is crucial."
• "We believe that our future success depends, to a large degree, on our ability to continue to conceive and develop new optical products and technologies to enhance the performance characteristics and methods of manufacture of existing and new products."

Industry Context

StockSavvy.ai notes that Precision Optics operates in highly competitive markets for medical devices and defense/aerospace products. The trend towards smaller, disposable medical imaging systems and the demand for compact, high-performance optical assemblies in satellite communications present significant market opportunities that align with the company's core technologies.

Comparison to Industry Standards

• The company's gross margin of 17.2% for FY2026 is below the typical gross margins seen in specialized manufacturing sectors, which can often range from 30-50% depending on product complexity and market position.
• The significant increase in revenue (65.2%) is a positive indicator, but it is crucial to assess if this growth is sustainable and profitable, especially given the continued net loss.
• The company's reliance on a few large customers (41% and 27% of revenue in FY2026) is a notable deviation from industry best practices, which emphasize customer diversification to mitigate risk.
• The waiver of the debt service coverage ratio covenant by Main Street Bank indicates a potential strain on the company's ability to meet its financial obligations, a situation that would be viewed critically by investors in more stable, larger industry players.

Legal Proceedings

• The company is not currently aware of any pending or threatened litigation against it or its officers and directors in their capacity as such that could have a material impact on its operations or finances.

Related Party Transactions

• The company rents a manufacturing facility in Gardner, Massachusetts from Equity Assets, Inc. (EAI). EAI was formerly owned by the company's founder, Richard E. Forkey, and is now owned by a trust controlled by his step-daughter, with Joseph N. Forkey (CEO) being one of five beneficiaries who each hold a 20% interest. Joseph N. Forkey is recused from any matters involving negotiations with the Company, including lease negotiations. His 20% interest in rents received from the Company is $21,600 per year.

Stakeholder Impact

• Shareholders: Potential dilution from future equity issuances; dependence on stock price appreciation for returns as no dividends are anticipated. Increased customer concentration poses a risk to revenue stability.
• Creditors: The company has secured a waiver for its debt service coverage ratio covenant, indicating potential financial strain, but has replaced it with a liquidity covenant.
• Suppliers: Dependence on a few key suppliers for critical materials could lead to supply chain disruptions if issues arise.
• Employees: The company emphasizes the importance of attracting and retaining skilled scientific and technical talent, indicating potential challenges in this area.

Next Steps

• Maintain a minimum liquidity of $2,000,000 in a Main Street Bank deposit account.
• Attain a Debt Service Coverage Ratio (DSCR) of 1.2x to potentially expand revolving line of credit availability to $1,250,000.
• Continue to develop new optical products and technologies.
• Transition new product programs from engineering design to commercial production.
• Seek patent protection for existing and new technologies.
• Continue to broaden awareness of new technology platforms and applications.

Key Dates

Recommendation

The company shows revenue growth and reduced net loss, which are positive signs. However, the increased customer concentration, continued net loss, and the recent debt covenant waiver are significant concerns. The company's ability to manage its debt obligations and diversify its customer base will be critical for future performance. Therefore, a 'hold' recommendation is appropriate pending further clarity on profitability and customer diversification.

Keywords

optical instruments, medical devices, defense, aerospace, endoscopes, microprecision optics, systems manufacturing, revenue